Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $287.27M in the quarter ending September 30, 2025, with 362.03% growth. This brings the company's revenue in the last twelve months to $740.64M, up 864.21% year-over-year. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.

• Revenue (ttm): $740.64M
• Revenue Growth: +864.21%
• P/S Ratio: 17.29
• Revenue / Employee: $1,402,727
• Employees: 528
• Market Cap: 13.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-